Vickie Y. Kim

Array ( [id] => 6637808 [patent_doc_number] => 20020086905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Gel for treatment of skin diseases and for disinfection of the skin' [patent_app_type] => new [patent_app_number] => 10/012303 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12358 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086905.pdf [firstpage_image] =>[orig_patent_app_number] => 10012303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1374475 [patent_doc_number] => 06562855 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Anaesthetic formulation comprising an NMDA-antagoinst and an alpha-2 adrenergic agonist' [patent_app_type] => B1 [patent_app_number] => 10/018007 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8937 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562855.pdf [firstpage_image] =>[orig_patent_app_number] => 10018007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568645 [patent_doc_number] => 20020165224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Use of y-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism' [patent_app_type] => new [patent_app_number] => 10/013971 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7696 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165224.pdf [firstpage_image] =>[orig_patent_app_number] => 10013971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082472 [patent_doc_number] => 20020082245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine' [patent_app_type] => new [patent_app_number] => 10/013142 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3225 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082245.pdf [firstpage_image] =>[orig_patent_app_number] => 10013142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936711 [patent_doc_number] => 20020061907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Medicinal compositions' [patent_app_type] => new [patent_app_number] => 10/005645 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5019 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061907.pdf [firstpage_image] =>[orig_patent_app_number] => 10005645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6569726 [patent_doc_number] => 20020165286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Dermal anti-inflammatory composition' [patent_app_type] => new [patent_app_number] => 10/003709 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7451 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165286.pdf [firstpage_image] =>[orig_patent_app_number] => 10003709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478732 [patent_doc_number] => 06451818 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Therapeutic use of 1,6-dimethyl-8-hydroxymethyl-10-methoxyergoline' [patent_app_type] => B1 [patent_app_number] => 09/998765 [patent_app_country] => US [patent_app_date] => 2001-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2202 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451818.pdf [firstpage_image] =>[orig_patent_app_number] => 09998765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766484 [patent_doc_number] => 20030100884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Iontophoresis disc pain blocker' [patent_app_type] => new [patent_app_number] => 09/995117 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6303 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100884.pdf [firstpage_image] =>[orig_patent_app_number] => 09995117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936616 [patent_doc_number] => 20020061855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Method of treating acne vulgaris using avermectin compound' [patent_app_type] => new [patent_app_number] => 09/988914 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4431 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061855.pdf [firstpage_image] =>[orig_patent_app_number] => 09988914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381324 [patent_doc_number] => 20020119954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Composition containing stabilized ascorbic acid, and uses thereof' [patent_app_type] => new [patent_app_number] => 09/988132 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4632 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119954.pdf [firstpage_image] =>[orig_patent_app_number] => 09988132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829333 [patent_doc_number] => 20020068762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Compositions for adhesion prevention' [patent_app_type] => new [patent_app_number] => 10/012711 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5477 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068762.pdf [firstpage_image] =>[orig_patent_app_number] => 10012711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1454181 [patent_doc_number] => 06462083 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Suppository base' [patent_app_type] => B1 [patent_app_number] => 10/010316 [patent_app_country] => US [patent_app_date] => 2001-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1655 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462083.pdf [firstpage_image] =>[orig_patent_app_number] => 10010316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814163 [patent_doc_number] => 20030073713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Inhibitors of ABC drug transporters at the blood-brain barrier' [patent_app_type] => new [patent_app_number] => 10/000113 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 15886 [patent_no_of_claims] => 393 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073713.pdf [firstpage_image] =>[orig_patent_app_number] => 10000113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289123 [patent_doc_number] => 20020054856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Nicotine mucosal spray' [patent_app_type] => new [patent_app_number] => 09/983554 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6672 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20020054856.pdf [firstpage_image] =>[orig_patent_app_number] => 09983554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490657 [patent_doc_number] => 06417179 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Ear wax solution' [patent_app_type] => B1 [patent_app_number] => 09/986237 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4840 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417179.pdf [firstpage_image] =>[orig_patent_app_number] => 09986237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1406647 [patent_doc_number] => 06524602 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Polymer delivery system in treatments for parasitic skin diseases' [patent_app_type] => B1 [patent_app_number] => 09/986209 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2931 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524602.pdf [firstpage_image] =>[orig_patent_app_number] => 09986209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002471 [patent_doc_number] => 06908925 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Treating skin wrinkles/fine lines with calcium channel inhibitors' [patent_app_type] => utility [patent_app_number] => 09/981751 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3539 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/908/06908925.pdf [firstpage_image] =>[orig_patent_app_number] => 09981751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6756426 [patent_doc_number] => 20030004203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Benzimidazole derivatives as modulators of IgE' [patent_app_type] => new [patent_app_number] => 09/983054 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6493 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004203.pdf [firstpage_image] =>[orig_patent_app_number] => 09983054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343760 [patent_doc_number] => 20020035059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Prevention or treatment of insomina with a neurokinin-1 receptor antagonist' [patent_app_type] => new [patent_app_number] => 09/978292 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15352 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035059.pdf [firstpage_image] =>[orig_patent_app_number] => 09978292 [rel_patent_id] =>[rel_patent_doc_number] =>)